PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM
Scott Kolodny,
Michael Vredenburg,
Jessica Zhang,
Brian Jamieson
Affiliations
Scott Kolodny
1 Sobi Pharmaceuticals, Medical Affairs, Durham, United States
Michael Vredenburg
2 Sobi Pharmaceuticals, Medical Affairs, Durham, United States
Jessica Zhang
3 Sobi Pharmaceuticals, Clinical Development, Durham, United States
Brian Jamieson
3 Sobi Pharmaceuticals, Clinical Development, Durham, United States
